Screening for Lung Cancer: Challenges for the Thoracic Surgeon

Surgical Oncology Clinics of North America

Volumn 20, Issue 4, 2011, Pages 619-635

  Stiles, Brendon M ^a   Altorki, Nasser K ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cancer; Lung; Screening; Surgery

Indexed keywords

AUTOFLUORESCENCE IMAGING; BRONCHOSCOPY; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; ENDOBRONCHIAL ULTRASONOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LUNG BIOPSY; LUNG CANCER; LUNG NODULE; OVERALL SURVIVAL; PATIENT REFERRAL; REVIEW; SPUTUM CYTODIAGNOSIS; SURVIVAL RATE; THORAX RADIOGRAPHY; THORAX SURGERY;

HUMANS; LUNG NEOPLASMS; MASS SCREENING; PHYSICIAN'S PRACTICE PATTERNS;

EID: 80053906934     PISSN: 10553207     EISSN: 15585042     Source Type: Journal    
DOI: 10.1016/j.soc.2011.07.001     Document Type: Review

References (77)

1. Jemal A., Siegel R., Xu J., et al. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300.
2. Fontana R.S., Sanderson D.R., Taylor, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis 1984, 130(4):561-565.
3. Melamed M.R., Flehinger B.J., Zaman M.B., et al. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984, 86(1):44-53.
4. Tockman M. Survival and mortality from lung cancer in a screened population: the John Hopkins study. Chest 1986, 89:325s.
5. Henschke C.I., McCauley D.I., Yankelevitz D.F., et al. Early lung cancer action project: a summary of the findings on baseline screening. Oncologist 2001, 6(2):147-152.
6. Henschke C.I., Naidich D.P., Yankelevitz D.F., et al. Early lung cancer action project: initial findings on repeat screenings. Cancer 2001, 92(1):153-159.
7. Sone S., Takashima S., Li F., et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998, 351(9111):1242-1245.
8. Doll R., Hill A.B. Smoking and carcinoma of the lung. Preliminary report. Br Med J 1950, 2(4682):739-748.
9. Brett G.Z. The value of lung cancer detection by six-monthly chest radiographs. Thorax 1968, 4:414-420.
10. Kubík A., Polák J. Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer 1986, 57(12):2427-2437.
11. Henschke C.I., McCauley D.I., Yankelevitz D.F., et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999, 354(9173):99-105.
12. Henschke C.I., Yankelevitz D.F., Libby D.M., et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006, 355(17):1763-1771.
13. Sone S., Li F., Yang Z.G., et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001, 84(1):25-32.
14. Garg K., Keith R.L., Byers T., et al. Randomized controlled trial with low-dose spiral CT for lung cancer screening: feasibility study and preliminary results. Radiology 2002, 225(2):506-510.
15. Tiitola M., Kivisaari L., Huuskonen M.S., et al. Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer 2002, 35(1):17-22.
16. Black C., de Verteuil R., Walker S., et al. Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literature. Thorax 2007, 62(2):131-138.
17. Nawa T., Nakagawa T., Kusano S., et al. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 2002, 122(1):15-20.
18. Nishii K., Ueoka H., Kiura K., et al. A case-control study of lung cancer screening in Okayama Prefecture, Japan. Lung Cancer 2001, 34(3):325-332.
19. Pastorino U., Bellomi M., Landoni C., et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003, 362(9384):593-597.
20. Patz E.F., Campa M.J., Gottlin E.B., et al. Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 2007, 25(35):5578-5583.
21. Swensen S.J., Jett J.R., Hartman T.E., et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003, 226(3):756-761.
22. Swensen S.J., Jett J.R., Sloan J.A., et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002, 165(4):508-513.
23. Diederich S., Thomas M., Semik M., et al. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol 2004, 14(4):691-702.
24. Diederich S., Wormanns D., Semik M., et al. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002, 222(3):773-781.
25. Gohagan J., Marcus P., Fagerstrom R., et al. Writing Committee, Lung Screening Study Research Group. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest 2004, 126(1):114-121.
26. MacRedmond R., Logan P.M., Lee M., et al. Screening for lung cancer using low dose CT scanning. Thorax 2004, 59(3):237-241.
27. Miller A., Markowitz S., Manowitz A., et al. Lung cancer screening using low-dose high-resolution CT scanning in a high-risk workforce: 3500 nuclear fuel workers in three US states. Chest 2004, 125(Suppl 5):15.
28. Sobue T., Moriyama N., Kaneko M., et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002, 20(4):911-920.
29. Bach P.B., Jett J.R., Pastorino U., et al. Computed tomography screening and lung cancer outcomes. JAMA 2007, 297(9):953-961.
30. McMahon P.M., Kong C.Y., Johnson B.E., et al. Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology 2008, 248(1):278-287.
31. Foy M., Yip R., Chen X., et al. Modeling the mortality reduction due to computed tomography screening for lung cancer. Cancer 2011, 117(12):2703-2708.
32. Goodman G.E., Thornquist M.D., Balmes J., et al. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst 2004, 96:1743-1750.
33. Strauss G.M. Randomized population trials and screening for lung cancer: breaking the cure barrier. Cancer 2000, 89(Suppl 11):2399-2421.
34. Sobue T., Suzuki T., Naruke T. A case-control study for evaluating lung-cancer screening in Japan. Japanese Lung-Cancer-Screening Research Group. Int J Cancer 1992, 50(2):230-237.
35. Flehinger B.J., Kimmel M., Melamed M.R. The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest 1992, 101(4):1013-1018.
36. Flieder D.B., Port J.L., Korst R.J., et al. Tumor size is a determinant of stage distribution in t1 non-small cell lung cancer. Chest 2005, 128(4):2304-2308.
37. Henschke C.I., Wisnivesky J.P., Yankelevitz D.F., et al. Small stage I cancers of the lung: genuineness and curability. Lung Cancer 2003, 39(3):327-330.
38. Raz D.J., Zell J.A., Ou S.H., et al. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 2007, 132(1):193-199.
39. McFarlane M.J., Feinstein A.R., Wells C.K. Clinical features of lung cancers discovered as a postmortem " surprise" Chest 1986, 90(4):520-523.
40. Burton E.C., Troxclair D.A., Newman W.P. Autopsy diagnoses of malignant neoplasms: how often are clinical diagnoses incorrect?. JAMA 1998, 280(14):1245-1248.
41. Henschke C.I., Yankelevitz D.F., Mirtcheva R., et al. ELCAP Group. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002, 178(5):1053-1057.
42. Pajares M.J., Zudaire I., Lozano M.D., et al. Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features. Cancer Epidemiol Biomarkers Prev 2006, 15(2):373-380.
43. Lam S., MacAulay C., leRiche J.C., et al. Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer 2000, 89(Suppl 11):2468-2473.
44. Libby D.M., Smith J.P., Altorki N.K., et al. Managing the small pulmonary nodule discovered by CT. Chest 2004, 125(4):1522-1529. Review.
45. McWilliams A.M., Mayo J.R., Ahn M.I., et al. Lung cancer screening using multi-slice thin-section computed tomography and autofluorescence bronchoscopy. J Thorac Oncol 2006, 1(1):61-68.
46. Ikeda N., Hayashi A., Iwasaki K., et al. Comprehensive diagnostic bronchoscopy of central type early stage lung cancer. Lung Cancer 2007, 56(3):295-302.
47. Belinsky S.A. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 2004, 4(9):707-717.
48. Tockman M.S., Gupta P.K., Myers J.D., et al. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol 1988, 6(11):1685-1693.
49. Belinsky S.A., Liechty K.C., Gentry F.D., et al. Promoter hypermethylation of multiple in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006, 66(6):3338-3344.
50. Palmisano W.A., Divine K.K., Saccomanno G., et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000, 60(21):5954-5958.
51. Spira A., Beane J.E., Shah V., et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007, 13(3):361-366.
52. Ding L., Getz G., Wheeler D.A., et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008, 455(7216):1069-1075.
53. Brower V. Biomarker studies abound for early detection of lung cancer. J Natl Cancer Inst 2009, 101(1):11-13.
54. Ostroff R.M., Bigbee W.L., Franklin W., et al. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One 2010, 5(12):e15003.
55. U.S.Preventive Services Task Force Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 151:716-726.
56. Hendrick R.E., Helvie M.A. United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol 2011, 196:W112-W116.
57. Eckersberger E., Finkelstein J., Sadri H., et al. Screening for prostate cancer: a review of the ERSPC and PLCO trials. Rev Urol 2009, 11(3):127-133.
58. Schroder F.H., Hugosson J., Roobol M.J., et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009, 360:1320-1328.
59. Andriole G.L., Crawford E.D., Grubb R.L., et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009, 360:1310-1319.
60. Libby D.M., Wu N., Lee I.J., et al. CT screening for lung cancer: the value of short-term CT follow-up. Chest 2006, 129(4):1039-1042.
61. Veronesi G., Bellomi M., Veronesi U., et al. Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening. Ann Thorac Surg 2007, 84(3):959-965. [discussion: 965-6].
62. Wallace M.J., Krishnamurthy S., Broemeling L.D., et al. CT-guided percutaneous fine-needle aspiration biopsy of small (< or = 1-cm) pulmonary lesions. Radiology 2002, 225(3):823-828.
63. Savage C., Walser E.M., Schnadig V., et al. Transthoracic image-guided biopsy of lung nodules: when is benign really benign?. J Vasc Interv Radiol 2004, 15(2 Pt 1):161-164.
64. Gildea T.R., Mazzone P.J., Karnak D., et al. Electromagnetic navigation diagnostic bronchoscopy: a prospective study. Am J Respir Crit Care Med 2006, 174(9):982-989.
65. Kurimoto N., Miyazawa T., Okimasa S., et al. Endobronchial ultrasonography using a guide sheath increases the ability to diagnose peripheral pulmonary lesions endoscopically. Chest 2004, 126(3):959-965.
66. Chella A., Lucchi M., Ambrogi M.C., et al. A pilot study of the role of TC-99 radionuclide in localization of pulmonary nodular lesions for thoracoscopic resection. Eur J Cardiothorac Surg 2000, 18(1):17-21.
67. Eichfeld U., Dietrich A., Ott R., et al. Video-assisted thoracoscopic surgery for pulmonary nodules after computed tomography-guided marking with a spiral wire. Ann Thorac Surg 2005, 79(1):313-316. [discussion: 316-7].
68. Partik B.L., Leung A.N., Müller M.R., et al. Using a dedicated lung-marker system for localization of pulmonary nodules before thoracoscopic surgery. AJR Am J Roentgenol 2003, 180(3):805-809.
69. Powell T.I., Jangra D., Clifton J.C., et al. Peripheral lung nodules: fluoroscopically guided video-assisted thoracoscopic resection after computed tomography-guided localization using platinum microcoils. Ann Surg 2004, 240(3):481-488. [discussion: 488-9].
70. Rose G., Hamilton P.J., Colwell L., et al. A randomised controlled trial of anti-smoking advice: 10-year results. J Epidemiol Community Health 1982, 36(2):102-108.
71. Sagawa M., Tsubono Y., Saito Y., et al. A case-control study for evaluating the efficacy of mass screening program for lung cancer in Miyagi Prefecture, Japan. Cancer 2001, 92(3):588-594.
72. Santambrogio R., Montorsi M., Bianchi P., et al. Intraoperative ultrasound during thoracoscopic procedures for solitary pulmonary nodules. Ann Thorac Surg 1999, 68(1):218-222.
73. Torre M., Ferraroli G.M., Vanzulli A., et al. A new safe and stable spiral wire needle for thoracoscopic resection of lung nodules. Chest 2004, 125(6):2289-2293.
74. Sortini A., Carrella G., Sortini D., et al. Single pulmonary nodules: localization with intrathoracoscopic ultrasound - a prospective study. Eur J Cardiothorac Surg 2002, 22(3):440-442.
75. Stiles B.M., Altes T.A., Jones D.R., et al. Clinical experience with radiotracer-guided thoracoscopic biopsy of small, indeterminate lung nodules. Ann Thorac Surg 2006, 82(4):1191-1196. [discussion: 1196-7].
76. Carter D., Vazquez M., Flieder D.B., ELCAP, NY-ELCAP, et al. Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer 2007, 56(2):193-199.
77. Gohagan J.K., Prorok P.C., Hayes R.B., Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team, et al. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 2000, 21(Suppl 6):251S-272S.